5 Top Performing European Stocks So Far in 2023

Page 5 of 5

1. ERYTECH Pharma S.A. (NASDAQ:ERYP)

YTD Gains as of March 23: 133%

France-based ERYTECH Pharma S.A. (NASDAQ:ERYP) makes red blood cell-based therapeutics for cancer and orphan diseases. ERYTECH Pharma S.A. (NASDAQ:ERYP) has gained about 133% in 2023 through March 23. ERYTECH Pharma S.A. (NASDAQ:ERYP) on March 22 posted its full-year 2022 results. Net loss in the period came in at €0.2 million, which was a €53.7 million improvement on a YoY basis.

3 hedge funds in the Insider Monkey database of hedge funds had stakes in ERYTECH Pharma S.A. (NASDAQ:ERYP) as of the end of the fourth quarter of 2022. The biggest stakeholder of ERYTECH Pharma S.A. (NASDAQ:ERYP) was Ian Cumming and Joseph Steinberg’s Leucadia National which had a $189,000 stake in the company.

You can also take a peek at 15 Most Promising Dividend Stocks According to Analysts and 15 Most Promising Long-Term Stocks.

Page 5 of 5